CRISPR Market stands at the precipice of a major paradigm shift driven by advanced manufacturing scaling, rising healthcare expenditures, and sophisticated digital facility platforms. Traditional mutagenesis tools struggle to match the strategic efficacy, long-term operational consistency, and high-precision performance profiles offered by modern gene editing alternatives. Specialized thermal...